XEROForm Brochure

LIMSA XEROFORM
Petrolatum dressing with 3% Bismuth Tribromophenate
PRODUCT DESCRIPTION
The only occlusive, non-adherent and bacteriostatic
primary wound contact layer. The active ingredient is 2,4,6
Bismuth Tribromophenate.
INDICATIONS FOR USE
It is intended for use as a primary contact layer in acute,
traumatic and chronic wounds such as lacerations, skin
graft and flaps, skin graft donor sites, post-surgical and
sutured wounds, abrasions, minor and partial thickness
burns, acute or chronic infected wounds, and wounds
with exposed tendons or bone.
MARKETS
Acute, traumatic, chronic and surgical wounds. Military
market.
PRODUCT HIGHLIGHTS
Value for money
The active substance in XEROFORM (Bi-Tribromophenate)
is bacteriostatic, protects the wound for infection and
promotes epithelialization. Additionally bismuth has a
deodorizing effect and helps to manage malodor in
wounds.
EFFECTIVE
XEROFORM is used for many years successfully in wound
healing. It is standard of care in burn treatment.
EASY TO USE
The dressing is bacteriostatic, non-adherent and occlusive
to provide a moist wound healing environment.
LITERATURE
Wendy Hansbrough, BS,RN,Et Al; Management of skin- Grafted burn Wounds with XEROFORM and
layers of dry Coarse-Mesh Gauze dressing results in excellent graft take and minimal nursing time;
Journal of Burn care & Rehabilitation 1995;531:543
David L. Feldman, Et Al; a prospective trial comparing Biobrane, Duoderm and Xeroform for skin graft
donor sites; Surgery Gynecology & Obstetrics,July 1991, 1:15- 173
W. Thomas Lawrence, MD F.A.C.T.S. Et Al. Acute wound care: Approach to acute wound management:
ACS Surgery online, July 2006
Kritian G Malpass, B.Sc, MD. Et Al; Comparison of donor-site healing under Xeroform and Jelonet
Dressings: Unexpected endings, Plastic and reconstructive surgery, August 2003, 430:439
25 Ubi Road 4 . #04-01
Weltech Industrial Bldg
Singapore 408621
Tel (65) 9834 96 64
[email protected]
www.mintcare.sg